SDD, HME, nanocrystal/particle
The depth of our bioavailability enhancement offering makes us a leader in addressing drug solubility and dissolution rate issues.
Particle engineering through micronization or spray drying
This expertise in particle engineering has been utilized in creating a full-service offering for dry powder inhaler (DPI) formulations.
Lipid multiparticulates, coated beads, mini-tablets and tastemasking
Multiparticulates (MP) allow the administered drug dose to be delivered as multiple discrete units each carrying a fraction of the dose. They can be easily swallowed, can better distribute the dose in the body and can be incorporated into many dosage forms
Compatible state-of-the-art equipment
Technologies available at this site
Experts in our field
Meet Deanna Mudie, Ph. D.
Deanna Mudie is a Principal Scientist in Research and Development at Lonza’s site in Bend, Oregon, USA. Since she joined Lonza in 2016, her focus has been on enabling bioavailability-enhancing amorphous solid dispersions by developing dosage form platforms and in vitro dissolution methodologies to predict bioperformance. Deanna earned her B.S.E. degree in Chemical Engineering and her Ph.D. in Pharmaceutical Sciences from the University of Michigan. She has seven years of predoctoral experience at Pfizer and Merck developing and manufacturing oral dosage forms from preclinical to commercial scale.
Sustainability